Minimal Residual Disease Assessment of Remission after Induction Therapy Is Superior to Morphologic Assessment for Risk Stratification in Childhood Acute Lymphoblastic Leukemia: A Report from the Children's Oncology Group (COG)
Sumit Gupta(Dayanand Medical College & Hospital), Brent L. Wood(University of Southern California), Mignon L. Loh(Seattle Children's Hospital), Eric Larsen(University of Massachusetts Chan Medical School), Stephen P. Hunger(Children's Hospital of Philadelphia), Elizabeth A. Raetz(NYU Langone Health), Naomi Winick(The University of Texas Southwestern Medical Center), Kimberly P. Dunsmore(University of Virginia), Leonard A. Mattano, Stuart S. Winter(New Mexico Cancer Center), Andrew J. Carroll(University of Alabama at Birmingham), Kelly W. Maloney(Children's Hospital Colorado), William L. Carroll(NYU Langone Health), Meenakshi Devidas(National Institutes of Health), Si Chen(Chinese Academy of Sciences), Cindy Wang(University of Florida), Michael J. Borowitz(Johns Hopkins University), Julie M. Gastier‐Foster(Nationwide Children's Hospital), Nyla A. Heerema(The Ohio State University), Patrick A. Brown(Haemonetics (United States))
Cited by 2
Related Papers
Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring
|Science|1999|11.6k
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
|Blood|2009|4.4k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2013|2.2k